- Home
- SCKT vs CYCC Comparison
SCKT vs CYCC Comparison
Compare SCKT & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- CYCC
- Stock Information
- Founded
- SCKT 1992
- CYCC 1992
- Country
- SCKT United States
- CYCC Malaysia
- Employees
- SCKT N/A
- CYCC N/A
- Industry
- SCKT Computer Manufacturing
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- CYCC Health Care
- Exchange
- SCKT Nasdaq
- CYCC Nasdaq
- Market Cap
- SCKT 9.3M
- CYCC 7.8M
- IPO Year
- SCKT 1995
- CYCC N/A
- Fundamental
- Price
- SCKT $1.21
- CYCC $8.20
- Analyst Decision
- SCKT
- CYCC
- Analyst Count
- SCKT 0
- CYCC 0
- Target Price
- SCKT N/A
- CYCC N/A
- AVG Volume (30 Days)
- SCKT 12.2K
- CYCC 3.7M
- Earning Date
- SCKT 07-30-2025
- CYCC 08-13-2025
- Dividend Yield
- SCKT N/A
- CYCC N/A
- EPS Growth
- SCKT N/A
- CYCC N/A
- EPS
- SCKT N/A
- CYCC N/A
- Revenue
- SCKT $17,750,643.00
- CYCC $14,000.00
- Revenue This Year
- SCKT $8.62
- CYCC $137.21
- Revenue Next Year
- SCKT N/A
- CYCC N/A
- P/E Ratio
- SCKT N/A
- CYCC N/A
- Revenue Growth
- SCKT 0.29
- CYCC N/A
- 52 Week Low
- SCKT $0.91
- CYCC $3.08
- 52 Week High
- SCKT $1.72
- CYCC $597.60
- Technical
- Relative Strength Index (RSI)
- SCKT 56.12
- CYCC 47.39
- Support Level
- SCKT $1.13
- CYCC $3.27
- Resistance Level
- SCKT $1.19
- CYCC $19.25
- Average True Range (ATR)
- SCKT 0.05
- CYCC 1.69
- MACD
- SCKT 0.01
- CYCC 1.80
- Stochastic Oscillator
- SCKT 71.43
- CYCC 31.66
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.